World's Best Scientists 2026 revealed!
Akihiro Matsukawa

Akihiro Matsukawa

D-Index & Metrics

Immunology

D-Index
50
Citations
8478
World Ranking
4258
National Ranking
164

Akihiro Matsukawa publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Akihiro Matsukawa sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 198 publications — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Akihiro Matsukawa D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Akihiro Matsukawa sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 50 D-Index — 15th percentile

15% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Akihiro Matsukawa is affiliated with Okayama University in Japan and has an extensive publication record primarily in the fields of medicine and biochemistry, genetics, and molecular biology. Their research spans important subfields including pulmonary and respiratory medicine, surgery, molecular biology, cancer research, and oncology.

Their work frequently addresses significant topics such as:

  • Prostate cancer treatment and research
  • Prostate cancer diagnosis and treatment
  • Bladder and urothelial cancer treatments
  • Cancer, lipids, and metabolism
  • Urinary and genital oncology studies
  • Radiopharmaceutical chemistry and applications
  • Renal cell carcinoma treatment

Matsukawa has published extensively in a range of scientific venues. Notable journals where multiple publications appear include:

  • Pathology International
  • European Urology Oncology
  • Scientific Reports
  • World Journal of Urology
  • PubMed

Recent papers by Matsukawa cover a variety of cancer-related topics across different types of research methodologies and publication outlets. Among them are:

  • "The chemokine monocyte chemoattractant protein-1/CCL2 is a promoter of breast cancer metastasis" (2023, Cellular and Molecular Immunology)
  • "Decreased miR-200b-3p in cancer cells leads to angiogenesis in HCC by enhancing endothelial ERG expression" (2020, Scientific Reports)
  • "SPRED2: A Novel Regulator of Epithelial-Mesenchymal Transition and Stemness in Hepatocellular Carcinoma Cells" (2023, International Journal of Molecular Sciences)
  • "Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Prostate Biopsy: A Systematic Review and Meta-analysis of Prospective Studies" (2024, European Urology Oncology)
  • "Nanog is a promising chemoresistant stemness marker and therapeutic target by iron chelators for esophageal cancer" (2021, International Journal of Cancer)

Collaboration plays a role in Matsukawa's research output, with frequent co-authors including:

  • Marcin Miszczyk
  • Tamás Fazekas
  • Paweł Rajwa
  • Shahrokh F. Shariat
  • Toshiaki Ohara

Best Publications

  • Innate immune response in Th1- and Th2-dominant mouse strains.

    Hiroyuki Watanabe;Kousuke Numata;Takaaki Ito;Katsumasa Takagi

  • Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis

    Masako Seki;Souichi Oomizu;Ken mei Sakata;Atsuko Sakata

  • Early Recruitment of Neutrophils Determines Subsequent T1/T2 Host Responses in a Murine Model of Legionella pneumophila Pneumonia

    Kazuhiro Tateda;Thomas A. Moore;Jane C. Deng;Michael W. Newstead

  • Endogenous monocyte chemoattractant protein-1 (MCP-1) protects mice in a model of acute septic peritonitis: cross-talk between MCP-1 and leukotriene B4.

    Akihiro Matsukawa;Cory M. Hogaboam;Nickolas W. Lukacs;Pamela M. Lincoln

  • Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion: synergism with hypercholesterolemia

    Masayuki Namiki;Seinosuke Kawashima;Tomoya Yamashita;Masanori Ozaki

  • Exaggerated hepatic injury due to acetaminophen challenge in mice lacking C-C chemokine receptor 2

    Cory M. Hogaboam;Cynthia L. Bone-Larson;Matthew L. Steinhauser;Akihiro Matsukawa

  • Expression and Contribution of Endogenous IL-13 in an Experimental Model of Sepsis

    Akihiro Matsukawa;Cory M. Hogaboam;Nickolas W. Lukacs;Pamela M. Lincoln

  • Aberrant inflammation and lethality to septic peritonitis in mice lacking STAT3 in macrophages and neutrophils.

    Akihiro Matsukawa;Kiyoshi Takeda;Shinji Kudo;Takako Maeda

  • Pivotal role of signal transducer and activator of transcription (Stat)4 and Stat6 in the innate immune response during sepsis.

    Akihiro Matsukawa;Mark H. Kaplan;Cory M. Hogaboam;Nicholas W. Lukacs

  • Stat3 in Resident Macrophages as a Repressor Protein of Inflammatory Response

    Akihiro Matsukawa;Shinji Kudo;Takako Maeda;Kousuke Numata

  • Pivotal Role of the CC Chemokine, Macrophage-Derived Chemokine, in the Innate Immune Response

    Akihiro Matsukawa;Cory M. Hogaboam;Nickolas W. Lukacs;Pamela M. Lincoln

  • Intervertebral disc cells produce tumor necrosis factor α, interleukin-1β, and monocyte chemoattractant protein-1 immediately after herniation: An experimental study using a new hernia model

    Masakazu Yoshida;Takafumi Nakamura;Akira Sei;Taro Kikuchi

  • A novel, visible light-induced, rapidly cross-linkable gelatin scaffold for osteochondral tissue engineering

    Tetsuro Mazaki;Yasuyuki Shiozaki;Kentaro Yamane;Aki Yoshida

  • Chemokines and innate immunity

    A. Matsukawa;C. M. Hogaboam;N. W. Lukacs;S. L. Kunkel

  • Monocyte chemoattractant protein-1/CCL2 produced by stromal cells promotes lung metastasis of 4T1 murine breast cancer cells

    Teizo Yoshimura;O. M. Zack Howard;Toshihiro Ito;Masaki Kuwabara

  • Neutrophil accumulation and activation by homologous IL-8 in rabbits. IL-8 induces destruction of cartilage and production of IL-1 and IL-1 receptor antagonist in vivo.

    A Matsukawa;T Yoshimura;T Maeda;S Ohkawara

  • Analysis of the cytokine network among tumor necrosis factor alpha, interleukin-1beta, interleukin-8, and interleukin-1 receptor antagonist in monosodium urate crystal-induced rabbit arthritis.

    Akihiro Matsukawa;Teizo Yoshimura;Takako Maeda;Toshihiro Takahashi

  • Endogenous MCP-1 influences systemic cytokine balance in a murine model of acute septic peritonitis.

    Akihiro Matsukawa;Cory M. Hogaboam;Nickolas W. Lukacs;Pamela M. Lincoln

  • Elevated levels of monocyte chemoattractant protein-1 in the aqueous humor after phacoemulsification.

    Motofumi Kawai;Motofumi Kawai;Toshihiro Inoue;Masaru Inatani;Masaru Inatani;Naoko Tsuboi;Naoko Tsuboi

  • Analysis of the inflammatory cytokine network among TNF alpha, IL-1 beta, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis.

    Akihiro Matsukawa;Teizo Yoshimura;Kazuhiko Miyamoto;Susumu Ohkawara

  • Production of IL-1 and IL-1 receptor antagonist and the pathological significance in lipopolysaccharide-induced arthritis in rabbits.

    A. Matsukawa;S. Ohkawara;T. Maeda;K. Takagi

Frequent Co-Authors

Steven L. Kunkel
Steven L. Kunkel University of Michigan–Ann Arbor
Cory M. Hogaboam
Cory M. Hogaboam Cedars-Sinai Medical Center
Nicholas W. Lukacs
Nicholas W. Lukacs University of Michigan–Ann Arbor
Yasuhiro Yoshida
Yasuhiro Yoshida Hokkaido University
Shinichi Toyooka
Shinichi Toyooka Okayama University
Teizo Yoshimura
Teizo Yoshimura Okayama University
Mitsuomi Hirashima
Mitsuomi Hirashima Kagawa University
Tsuneo Morishima
Tsuneo Morishima Okayama University
Ji Ming Wang
Ji Ming Wang National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring complementary healthcare fields can open diverse career opportunities. Nursing programs are a popular pathway, with many students seeking flexible education options. To find programs with less competitive admission, you can explore lpn schools easy to get into. These provide a stepping stone into healthcare careers, often requiring less stringent entry requirements.

Advancing further, some choose to specialize as nurse practitioners. Identifying which nurse practitioner program is easiest can help balance workload with study demands. This approach helps students gain advanced skills efficiently while maintaining manageable schedules.

Mental health is another key area closely related to Immunology, especially with growing awareness of psychoneuroimmunology. Programs ranked among the best psychiatric mental health nurse practitioner programs online offer strong clinical placements, ensuring practical experience in this vital specialty.

For many, cost is a major consideration. There are options to pursue quality education at a lower cost by choosing from the cheapest online pmhnp programs, enabling access to advanced degrees without excessive financial burden.

Best Scientists Citing Akihiro Matsukawa

Trending Scientists

Recently Published Articles